Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
52.36
+3.60 (7.38%)
At close: Jun 18, 2026, 4:00 PM EDT
51.32
-1.04 (-1.99%)
After-hours: Jun 18, 2026, 6:08 PM EDT

Spruce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1441201812026105
Market Cap Growth
5568.40%573.89%-85.25%364.30%-75.29%-81.47%
Enterprise Value
97.1571.03-18.5428.24-47.0121.98
Last Close Price
52.3687.1131.50219.7582.28334.50
PS Ratio
--3.6111.92--
PB Ratio
2.070.360.621.570.380.94
P/TBV Ratio
0.150.200.601.480.380.94
EV/Sales Ratio
---3.772.80--
EV/EBITDA Ratio
--0.33-1.00-
EV/EBIT Ratio
--0.33-0.99-
EV/FCF Ratio
--0.33-1.13-
Debt / Equity Ratio
0.020.000.030.040.070.06
Net Debt / Equity Ratio
-0.14-0.15-1.26-1.20-1.06-0.74
Net Debt / EBITDA Ratio
1.401.330.651.771.541.97
Net Debt / FCF Ratio
1.611.460.652.761.752.30
Asset Turnover
-00.070.1100
Quick Ratio
4.594.852.543.946.3510.03
Current Ratio
4.675.172.904.186.7210.36
Return on Equity (ROE)
-3.67%-21.61%-100.70%-66.10%-51.35%-32.43%
Return on Assets (ROA)
-62.29%-74.34%-75.29%-54.85%-44.58%-29.07%
Return on Invested Capital (ROIC)
-2235.16%-2066.38%-1028.31%-869.59%-247.21%-212.29%
Return on Capital Employed (ROCE)
-77.90%-100.18%-102.61%-68.11%-49.56%-31.08%
Buyback Yield / Dilution
-72.07%-39.34%-7.14%-63.68%-0.71%-289.93%
Total Shareholder Return
-72.07%-39.34%-7.14%-63.68%-0.71%-289.93%